Canada Clinical AI Add-On Market Reaches CAD 24.0 Million as 12,019 Publicly Funded Scribe Licences Come Up for Renewal

TORONTO, 25 October 2026 — Canada’s clinical artificial intelligence add-on layer reached CAD 24.0 million in 2025 and is forecast to reach CAD 97.0 million by 2033, a CAGR of 19.1 per cent, inside a total physician-office software market rising from CAD 213.9 million to CAD 339.8 million at 6.0 per cent, according to a new report from Pheonix Research. The add-on layer grows from 11.2 per cent of that total to 28.5 per cent over the period.

Almost none of the 2025 spend was bought by doctors. Roughly CAD 18.0 million of the CAD 24.0 million layer consists of fully funded one-year licences issued through Canada Health Infoway’s AI Scribe Program, which launched in June 2025, required vendor agreements by 31 December 2025, and covered baseline functionality for twelve months only. 12,019 primary care clinicians enrolled between June 2025 and February 2026 — about 24.5 per cent of the country’s roughly 49,150 family physicians — of whom 7,400 were active users, defined as ten or more uses a month.

Those licences are now lapsing, and the renewal is the market. On the report’s CAD 1,500 per-seat assumption, the funded cohort is approximately CAD 18.0 million of annualised revenue with no contractual reason to exist after year one. If habitual users renew at list price, the layer retains about CAD 11.1 million; if half of them do, CAD 5.6 million; if platform owners bundle the capability at 60 per cent of list, CAD 6.7 million.

The premise is right; the buyer was the province

“Canada does not have an EMR adoption problem. It has a replacement problem that nobody wants to pay for, and a much more interesting problem sitting on top of it.”

By 2024, 95 per cent of Canadian physicians were already using electronic records for clinical notes, up from 87 per cent in 2021 and 39 per cent in 2010, and 65 per cent run exactly one system. The seat base is not growing into the gap either: CIHI counted 99,555 physicians in 2024 at 241 per 100,000 population, down from 243, with family physicians per 100,000 falling for a second consecutive year from 124 in 2022 to 119 in 2024 — and, for the first time since the mid-1990s, family physician supply growing more slowly than the population.

With no unserved seats left, the only growth available in the core layer is price and attach. Hence a market that grows 6.0 per cent overall while its fastest-growing layer compounds near 19 per cent.

Two authoritative documents, five weeks apart, measuring different things

The report sets the independent national evaluation against Ontario’s Auditor General report and finds them compatible but unequally reassuring.

In June 2026, the Centre for Digital Health Evaluation at Women’s College Hospital reported that clinicians saved 1.11 hours a week in work hours plus nearly an hour after hours; same-day note completion rose from 55.9 per cent to nearly 75 per cent; delayed documentation fell from 9.8 per cent to under 3 per cent; and more than 90 per cent of clinicians said the tools added value.

In May 2026, Ontario’s Auditor General, reviewing a provincial procurement of 20 AI documentation systems, found that nine hallucinated — fabricating content, or proposing referrals and blood tests the physician never ordered; twelve transcribed a different drug than the one prescribed; and seventeen missed key patient mental-health details. Some vendors had not submitted third-party audit reports, certifications or threat risk assessments, and four systems were approved anyway.

“Those two documents are not in conflict. They measure different things: whether clinicians like the tool, and whether the tool is correct. The market’s next phase is not an adoption curve. It is an assurance curve, and the incremental spend accrues to whoever can sell verification rather than convenience.”

Four vendor groups hold 90.6 per cent of Ontario seats — and none of them owns the engine

The only public seat-level census in the country is OntarioMD‘s vendor-reported count: 27,101 community seats, of which TELUS Health holds 39.0 per cent across three offerings, QHR’s Accuro 28.7 per cent and the WELLSTAR group 22.9 per cent. 91.5 per cent of those seats are hosted rather than local, which means the cloud migration that drove a decade of repricing is complete.

The add-on is being absorbed by those seat owners rather than contested by specialists. Accuro now ships Accuro AI Scribe, powered by Heidi, integrated inside the EMR.

“The clinician does not choose a scribe and then connect it — they choose an EMR and receive one.”

The report argues that this leaves the defensible product in assurance rather than documentation: extraction of every clinical assertion, an audit trail separating what the physician said from what the model generated, and an enforced attestation that a human reviewed the note — which is precisely what the Auditor General recommended the province build into its procurement controls.

Methodology and band

The report sizes the annual software spend of roughly 67,800 Canadian community physician seats across two layers, in Canadian dollars because that is the currency the spend occurs in. Core layer: CAD 189.8 million in 2025 to CAD 242.8 million in 2033 at 3.1 per cent, on CAD 2,800 per seat — deliberately below the CAD 4,800-a-year Enhanced Use subsidy a provincial payer has historically provided, because that subsidy bundles connectivity a software-only measure should not claim. Add-on layer: CAD 24.0 million to CAD 97.0 million at 19.1 per cent, on CAD 1,500 per attached seat drawn from published vendor list pricing of CA$100 to CA$150 a month for unlimited scribing.

The band runs from 4.6 per cent in the low case, with 50 per cent attach at CAD 1,650 (CAD 306.3 million by 2033), through the 6.0 per cent base at 70 per cent attach and CAD 1,800 (CAD 339.8 million), to 7.5 per cent in the high case at 85 per cent attach and CAD 2,100 (CAD 380.2 million). No second construction is presented as corroboration.

“One construction with a stated band, and the assumptions above it, is worth more than two that share the same guess.”

The report names three falsifiers: a disclosed acquisition of a Canadian AI scribe vendor by a platform owner; renewal conversion materially below the 61.6 per cent habitual-use rate; and any provincial requirement that AI-generated notes be flagged, attested or separately audited.

About the report

Canada EMR and Clinical AI Add-On Market Report, Size, Share and Forecast 2026-2033 — read the full report. It covers the two-layer sizing and forecast to 2033, the Ontario seat census, the value chain from provincial subsidy to clinician licence, the 2026 renewal arithmetic, the assurance gap between the national evaluation and the provincial audit, and the four ranked risks with their falsifiers.

Accompanying analysis: Nine of Twenty AI Scribes Proposed Care the Doctor Never Ordered.

About Pheonix Research

Pheonix Research publishes market intelligence built from primary sources — regulators, statistical agencies, audit offices, procurement records and company filings — with stated construction methods, explicit bands and named falsifiers. Every forecast is traceable to the assumptions behind it.

Media enquiries: Pheonix Research, press room via pheonixresearch.com.